Sorin Investments financed a $7 million Series A fundraising round for Nivaan Care, a chain of single-specialty interventional pain care clinics. Existing backers W Health Ventures, Endiya Partners, and Rebright Partners also participated in the round.

Key Highlights

• Nivaan Care raises $7 million in Series A funding to expand mental healthcare services across India.
• Sorin Investments leads the round, signaling strong investor confidence in India’s growing healthtech ecosystem.

The company's $4.25 million initial finance, headed by Endiya Partners with participation from W Health Ventures, was obtained in February 2025. This Series A comes after that.

The additional funds will be used to develop minimally invasive pain management techniques, improve clinical and operational infrastructure, and broaden Nivaan's clinic network in several Indian cities.

Nivaan treatment, a New Delhi-based company founded in 2023, uses a multidisciplinary treatment strategy that combines pain doctors, physiotherapists, and care coordinators to run single-specialty clinics targeting chronic diseases such back, knee, and neck pain. 

Currently serving patients in Delhi-NCR, Mumbai, and satellite markets like Jaipur and Lucknow, the chain has performed almost 5,000 minimally invasive treatments and over 40,000 consultations.

With the additional funding, Nivaan intends to strengthen its operational foundation, expand its physical presence into new cities like Bengaluru, and keep developing patient-centered pain treatments that are suited to Indian healthcare requirements.

Also Read: Proptech Firm PropertyPistol Raises Rs 25 Cr in Pre-Series B Funding

The company claims that by concentrating on non-surgical and minimally invasive therapies, their multidisciplinary, evidence-led approach tackles the fragmented nature of chronic pain care and provides an alternative to basic physiotherapy or invasive surgery.